Aller au contenu principal
Accès ouvert déclaré 2026 article

Deep Learning Survival Analysis with Time-Varying Covariates: Extending PyCox to Assess COVID-19 Antiviral Treatments and Long-COVID Associations

0Citations signalées — pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Abstract Objective To extend the PyCox to accommodate time-varying covariates using counting process data, addressing immortal time bias in survival analysis. Materials and Methods We modified PyCox to support counting process data structures for time-varying covariates and applied it to 2,246,913 Medicare beneficiaries aged ≥65 with COVID-19 (January-September 2022; 2,785,807 longitudinal records). We compared traditional Cox regression, original PyCox, and modified PyCox in estimating associations between early antiviral treatment (nirmatrelvir or molnupiravir) and long-COVID. Performance metrics included concordance index (C-index), integrated Brier score (IBS), and integrated negative binomial log-likelihood (IBLL) and time-dependent Area Under the Receiver Operating Characteristic Curve (AUC), Brier score, and permutation importance. Results Among patients, 19.5% received nirmatrelvir, 2.6% received molnupiravir, and 14% developed long-COVID. Traditional Cox and modified PyCox produced concordant hazard ratios (HR) for nirmatrelvir (0.874 and 0.878) and molnupiravir (0.909 and 0.918); original PyCox estimated stronger associations (HR = 0.822 and 0.879). The treatment-effect difference formed a gradient: 3.5-4.0 percentage-points for time-varying models, 4.6 for time-fixed Cox, and 5.7 for time-fixed PyCox. Discrimination, calibration, and fit were comparable overall; modified PyCox showed higher time-dependent AUCs (0.536-0.609) than time-fixed PyCox (0.481-0.519) and relied on largely different top predictors. Modified and original PyCox trained in 1 minute 14 seconds and 3 minutes 18 seconds, versus 5 minutes for traditional Cox. Discussion Treatment-contrast magnitude and covariate importance varied by models, suggesting temporal covariate structure and modeling approach jointly influence treatment-effect estimates. Conclusion Extending PyCox to accommodate time-varying covariates improves computational efficiency while maintaining estimation accuracy comparable to standard time-varying methods.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Deep Learning Survival Analysis with Time-Varying Covariates: Extending PyCox to Assess COVID-19 Antiviral Treatments and Long-COVID Associations
Date Crossref
04/09/2026
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Statistical Methods and InferenceAdvanced Causal Inference TechniquesCOVID-19 Clinical Research Studies

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.